industry collaboration, many of the greatest advances in medical and surgical care would not have been possible. Bhandari et al. 6 have estimated the average cost of bringing a new drug to market at approximately $500 million. They note that the "funding limitations in most peerreviewed agencies provides a compelling rationale" for partnering with industry.
Given the justifiably heightened current awareness and scrutiny of COI, it is uncertain how we will resolve COI issues for physician-industry relationships and research funding. What is clear is that physician-industry relationships and funded research potentially create bias; however, without industry-sponsored research, society runs the risk of missing out on health care innovation that will ultimately better serve health care needs. Doctors, companies, and government leaders have attempted to regulate COI issues, but the opinion of health care consumers or society itself has not been determined and must be if we are to apply principles of evidence-based medicine. [12] [13] [14] [15] The goal of this study is to determine the opinions of people in the general public regarding the role of surgeons in clinical research and the industry funding of such. Key components of the process will be explored, including opinions on research funding sources, quality of care, control of research data, and regulation of COI.
Methods

Survey Design
After obtaining approval from the University of British Columbia Clinical Research Ethics Board, the authors developed a survey to test the key components of surgeon-industry research and potential COI. Multiple iterations of the survey were generated to ensure question clarity and inclusion of relevant content. Each rendition was piloted on small samples of the general population. The final survey is presented in Appendix 1.
Survey Administration
The survey was posted on www.spineuniverse.com with no financial connection or compensation. SpineUniverse is owned by a medical communications company involved in websites and continuing medical education. No medical company owns any shares or options of SpineUniverse. All content on SpineUniverse follows the highest web standards of financial disclosures, independence, and separation of editorial and advertisement. The site is a member of the HONcode, an independent group that sets standards for websites. The editorial board includes representatives from both operative and nonoperative spine specialties. Approximately 80% of the traffic on www. spineuniverse.com is generated via search engines from people with questions about spine health.
All respondents voluntarily filled out the survey. As an incentive to participate, respondents were entered into a random drawing to win a portable media device. Viewers of the website were not allowed to see the survey until they registered and agreed to proceed. No financial connection or incentive was otherwise afforded to the authors or respondents. The survey was posted on the website for 2 weeks, then all completed surveys were collected and responses tabulated.
To determine if there was any bias in the cohort of survey responders versus the population that usually visits spineuniverse.com, the demographics of the 2 groups were compared (Tables 1 and 2) .
Statistical Methods
Demographic and general survey results were summarized as a percentage for each answer and expressed as a 95% CI. Six descriptors (age, sex, education level, insurance status, employment, and patient status-that is, currently seeking or has received treatment for a condition that requires surgery with an implantable device) were selected for subgroup analyses in an attempt to identify variables that predispose respondents to certain opinions. Subgroup analyses were conducted by performing logistic regression for each question. Subcategories within each subgroup for each question were analyzed. Statistical significance was set at p < 0.05.
Sample Generalizability
Respondent demographics were tallied and expressed as percentages of key demographic variables, as listed in Table 1 . These data were compared with US census data (Appendix 2). Sample weight was calculated for each respondent to construct a weighted sample that had the same marginal proportions as the target population on the factors sex, age, and education level. After weighting the sample, response proportions were tallied and compared with those of the unweighted sample.
Results
Demographics, Survey Responses, and Subgroup Analysis
A total of 541 surveys were completed; 40 were removed because of missing essential core data, leaving 501 surveys for analysis. Table 1 displays the demographic characteristics of the sample of respondents. Although some of the metrics are different, the demographics of the respondents are similar to those of Spine Universe users ( Table 2) . The sample has a higher proportion of elderly individuals, women, and more highly educated people than the US general population (Appendix 2). Table 3 summarizes the responses to the survey. Eight-two percent of respondents felt that research funded by medical companies can be valuable for patients, but 55% of respondents felt that the source of funding for a study has the potential to affect patients' quality of care (Table 3) . Over two-thirds of respondents felt that both industry-funded and government-funded research could be equally objective. Ninety-one percent of respondents felt that surgeon input is important for industry-funded studies, and most felt that companies and doctors should have control over data together (Table 3 ). Almost 80% of respondents felt that industry-funded research should have doctors involved in the process. More than 70% of respondents thought that a combination of groups including doctors, universities, government representatives, and company representatives should be involved in regulating COI. Company and government representatives are least desirable to be included in the COI regulation process ( Table 3) .
The subgroup analysis of question responses is summarized in Table 4 . Overall there were very few significant differences in opinion based on stratification of the assigned subgroups.
Sample Generalizability
The survey respondents in this study were much more likely to be older, female, and more educated than the general US population (conclusion illustrated by comparison of data from Table 4 and Appendix 2). By weighting the survey respondent sample to more closely represent that of the US population data from Appendix 2, a postulated set of "weighted responses" was calculated. This theoretically represents what the responses to our survey would be had a true cross-section of the American population answered it. Table 5 highlights the comparison of the unweighted (true responses) to the weighted (postulated responses based on US census data) and shows that there are very few percentage differences. This analysis yielded a range of difference in response types of 0%-6.5%. It suggests that there are minimal differences between our survey population responses and what might be expected from a more representative cross-section of the US population, based on answers adjusted for sex, education level, and age.
Discussion
The purpose of this study was to assess opinions of the North American public regarding surgeon-industry COI as it pertains to industry-funded research. The topics addressed in the survey are relevant because as government and professional societies face budgetary restraints, more dependence has been placed on industry to fund research. Furthermore, physicians are often partnered with industry in the development and research of health care innovations. 30 The percentage of industry-sponsored research in orthopedics has grown significantly in the last 30 years and continues to do so, with over half of all research funding now connected to industry. 31 Industry- There is evidence to support heightened vigilance with respect to the impact of industry sponsorship on health care research. Bekelman et al. 3 concluded that medical research investigators as well as academic institutions have widespread financial ties to the medical industry that funds the research. Conflict of interest arising from these ties can influence research in important ways. Although controversial, findings in clinical trials funded by for-profit organizations tend to have more positive outcomes due to biased interpretation of trial results. 1 This concern permeates the current literature. 2, 19, 20, 26 Respondents to our survey appear to share the same apprehension, with 50% feeling the source of funding can affect the quality of the care they receive. Interestingly, however, almost 80% of respondents in our survey felt that industry-funded research is valuable and only 6% said it is not. Thus, there appears to be cautious support for industry to provide funding for research.
Researchers' ability to perform scientifically independent studies without restriction appears to be threatened by industry sponsorship. Deyo et al. 9 have reported on a series of cases in which researchers have been denied access to or control of data in industry-sponsored studies, a situation that the majority of the scientific community would consider intolerable. Approximately two-thirds of respondents to our survey felt that doctors and companies should jointly control research data. In our survey, when respondents only picked one choice (that is, doctors or companies) to control data, they favored doctors. This question did not specifically ask to choose only doctors Overall there were very few significant differences in opinion based on subgroup analysis. If people had undergone or were planning on undergoing an operation that involved implantation of a surgical device, they were designated as "patients." These respondents tended to feel that company-funded education events were ethical and would help improve quality of care. or companies, but it appears that respondents prefer that doctors or the principle researcher have a role in overall data control. Over 75% of respondents in this study felt that medical companies should not be allowed to do clinical studies without physician input, and over 85% of respondents felt that surgeon input is valuable to industryfunded clinical studies. There appear to be differing trends in the quality of research depending on the type of financial COI disclosed by the physician scientist. Presentations authored by individuals with a COI related to royalties, stock options, consulting, or employee status were significantly more likely to describe positive findings compared with studies authored by individuals with a COI related to research or institutional funding. 24 A study investigating research presented at the Scoliosis Research Society generated similar results. 26 About two-thirds of respondents to our survey said that government and industry funding for research can be equally objective. Authors of other studies have drawn similar conclusions, citing that study participants generally trust in the scientific process and universities', government's, and professional associations' ability to regulate COI. 25 Of the remaining one-third of respondents who did not feel government-and industry-supported research could be equally objective, about two-thirds felt that government-funded research tends to be more objective. These opinions appear to be supported by recent reviews of orthopedic and spine literature. Industry-funded total hip arthroplasty research reported positive outcomes in 93% of studies, whereas independently funded researchers reported positive results in only 37% of studies. 11 In a study of articles published in Spine, it was found that the presence of industry funding correlated with a 1.6 times greater chance that positive results in favor of the device would be found. 28 Traditional explanations for this are biased study design, result interpretation, or publication bias. 28 One must also consider the incentive for industry to fund research and the likelihood of their doing this with an intervention more likely to succeed than not. Though provocative, these findings do not prove that bias exists in the research funded by industry, but they serve to highlight the potential and necessity for careful, objective, and transparent scrutiny.
It should be noted that the presence of funding, whether it be from government or industry, in and of itself may lead to COI, because the ability to receive further funding may be influenced by the researchers' ability to generate publications. 30 Therefore, industry-sponsored research does not hold a monopoly on COI generation. Career advancement and promotion for an academic researcher is often tied to that individual's ability to publish research papers. Acquisition of prestigious government-funded grants also may help promote a researcher's career and is often dependent on a person's ability to publish the results. 21 Therefore, nonfinancial incentives to publish studies, which may or may not be tied to government funding, do play a role in COI as well. 21 The majority of respondents in this study felt that surgeons performing research on products in which they have a financial interest should be regulated. About 20% said no regulation is necessary. Similar proportions of respondents felt that surgeons should be allowed to perform research on products in which they have a financial interest as long as regulations are established to limit COI. These sentiments appear in line with official statements made by professional societies, 10,21 government officials, 17 and industry representatives. 27 Doctors, 7,22 medical industry, universities/hospitals, 25 and government regulation of COI have all increased. 12, 10, 30 Greater than 70% of respondents felt that a combination of these groups should be involved in COI regulation. About 32% felt that a combination of groups was best suited to establish guidelines and perform regulation of surgeon-industry COI; 22.9% felt that doctors and their professional societies alone were best suited to perform regulation. Almost half of all respondents felt that either government or company representatives should not be involved in the COI regulation process. This study did not have the capability of determining why this is, but it appears that based on previous reports, people generally trust physicians to a great extent and distrust politicians. 16 A recent Harris poll found that on average 85% of people trusted doctors to tell the truth, while only 35% trusted congressmen. * The unweighted sample represents the actual survey responses. The weighted sample represents the postulated proportions of responses based on weighting the sample to more closely reflect the demographics of the US population. This is in essence a control for the skewed nature of the sample population that responded to the survey, which was typically older, more female, and more highly educated than a representative cross-section of the US population. There was very little difference in projected responses for the weighted sample compared to the unweighted sample responses. Abbreviation: Diff = Difference.
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Based on the demographics component of this study (Appendix 2; http://www.census.gov/prod/cen2000/index. html), it appears that our sample population is less represented by the 18-to 29-year-old age range and has higher representation in the 50-to 59-year-old range than the US census data. Otherwise our population was similar in age representation. There are about 10% more females in our study than the US 2000 census report (http://www.census. gov/prod/cen2000/index.html). Also, respondents in our study population were much more likely to have a graduate degree, college diploma, or high school education than the general US public. For the SpineUniverse website, the respondent cohort was similar in demographic characteristics to the general users of this website.
We feel that patient opinion and values are very important considerations in all aspects of health care. How should patient or general public opinions be weighted in the decision-making and regulating process? Issues of COI are complex, so how do we appropriately educate patients or the broader public on the important subtleties of the subject? We made a strong effort to give balanced and concise education on the subject in the preamble to our survey, so as to account for this confounding affect. Many of the responses in this survey were in line with the opinions of government, industry, and professional societies, indicating an understanding of the COI concepts and thus supporting the validity of the questionnaire.
This study had numerous limitations. Three of the authors are consultants (C.G.F., M.F.S.D., and C.P.D.) for spinal implant companies, and Vancouver General Hospital receives educational support from industry. The results of the study therefore could be considered self-serving. The other authors have no COI and therefore provided checks and balances. Because survey respondents were enrolled through a spine health website, volunteer and selection bias was unavoidable; however, it is possible that an interest in spine health information or research is beneficial. 29 The survey has not undergone stringent psychometric evaluation, and its validity and reliability could be challenged. The survey did undergo numerous iterations to ensure face and content validity, but more in-depth evaluation was not practical. The website only represented one domain of health care, namely spine pathology and treatment.
This study also has multiple strengths. By making the survey web-based, we were able to reach a broad sample of the population and larger numbers than previous studies. 18 There are strengths in limiting our study population to those who are visiting a website seeking medical information. While it has been suggested that public health survey studies attempt to sample as accurate a cross-section of the population as possible, 8 this premise may not be necessary. If policy and regulatory guidelines are to be developed based on people's opinions, it may be most suitable to poll those who have the most interest in the subject and therefore the greatest stake in the issue.
Conclusions
This study offers evidence into public opinion with regard to the complex issue of industry funding for medical research. It also helps us understand the general public's perception of how funding sources for research will affect patient care. While the elimination of COI and bias across medical research is an admirable goal, it will be difficult to achieve. Physicians must play roles as educators, researchers, and administrators, and industry support is a necessary component of research funding. Objective, transparent evidence-based regulation is probably the better approach to achieve a balance between eliminating overt COI and bias while ensuring innovative research and knowledge generation to benefit society. 4 The participants of this survey support regulated industry-sponsored research and feel clinicians should be involved in this research. Hopefully, this information will allow politicians and other health care regulators to form appropriate and representative evidence-based guidelines. Concerns have developed that financial interest of the companies might influence the outcome or findings of medical company sponsored research. The other equally important concern is that without funding by medical companies, research might not get done and society may be deprived of new medical discoveries that lead to better health for the population.
In light of these concerns, many surgeons, medical companies, and even governments want to understand patient's perception of research that is funded by medical industry or government sources. You can help them understand by answering the following questions. 
